Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.

Suppr

超能文献

作者信息

Hoang Quan V, Kiernan Daniel F, Chau Felix Y, Shapiro Michael J, Blair Michael P

出版信息

Arch Ophthalmol. 2010 Aug;128(8):1080-1. doi: 10.1001/archophthalmol.2010.145.

DOI:10.1001/archophthalmol.2010.145

PMID:20697016

Abstract

摘要

相似文献

Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.

Arch Ophthalmol. 2010 Aug;128(8):1080-1. doi: 10.1001/archophthalmol.2010.145.

Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.玻璃体内注射贝伐单抗作为早产儿视网膜病变的抗血管内皮生长因子治疗：一项形态学研究。

Arch Ophthalmol. 2008 Aug;126(8):1161-3. doi: 10.1001/archophthalmol.2008.1.

Off-label use of bevacizumab in retinopathy of prematurity.

Retina. 2009 Feb;29(2):284; author reply 284-5. doi: 10.1097/IAE.0b013e31818a1ee7.

Reactivation of retinopathy of prematurity after bevacizumab injection.注射贝伐单抗后早产儿视网膜病变复发。

Arch Ophthalmol. 2012 Aug;130(8):1000-6. doi: 10.1001/archophthalmol.2012.592.

Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.早产儿视网膜病变中玻璃体内注射贝伐单抗（阿瓦斯汀）后行玻璃体切除术。

Retina. 2010 Apr;30(4 Suppl):S32-6. doi: 10.1097/IAE.0b013e3181ca146b.

Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.玻璃体内注射贝伐单抗治疗早产儿视网膜病变出现显著治疗失败。

Arch Ophthalmol. 2012 Jun;130(6):801-2. doi: 10.1001/archophthalmol.2011.1802.

Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.单侧注射贝伐单抗治疗早产儿视网膜病变的双侧效应

JAMA Ophthalmol. 2013 Aug;131(8):1099-101. doi: 10.1001/jamaophthalmol.2013.400.

Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.玻璃体内注射贝伐单抗与激光治疗 1 型早产儿视网膜病变：荧光血管造影结果报告。

Ophthalmology. 2014 Nov;121(11):2212-9. doi: 10.1016/j.ophtha.2014.05.015. Epub 2014 Jul 4.

A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.玻璃体内注射贝伐单抗与早产儿视网膜病变中的双嵴形成的罕见关联。

J Pediatr Ophthalmol Strabismus. 2014 Oct 8;51 Online:e66-8. doi: 10.3928/01913913-20140930-01.

Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies.大孕周早产儿玻璃体内注射抗血管内皮生长因子治疗侵袭性早产儿视网膜病变的荧光素血管造影

Acta Ophthalmol. 2014 Dec;92(8):810-3. doi: 10.1111/aos.12461. Epub 2014 Jun 9.

引用本文的文献

Intravitreal bevacizumab to treat retinopathy of prematurity in 865 eyes: a study to determine predictors of primary treatment failure and recurrence.玻璃体腔内注射贝伐单抗治疗 865 只眼早产儿视网膜病变：一项确定主要治疗失败和复发预测因素的研究。

Int Ophthalmol. 2022 Jul;42(7):2017-2028. doi: 10.1007/s10792-021-02198-x. Epub 2022 Jan 20.

Bevacizumab or laser for aggressive posterior retinopathy of prematurity.贝伐单抗或激光治疗侵袭性早产儿视网膜病变。

Taiwan J Ophthalmol. 2018 Oct-Dec;8(4):243-248. doi: 10.4103/tjo.tjo_69_18.

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.血管内皮生长因子（VEGF）抑制剂治疗早产儿视网膜病变安全性的系统评价与Meta分析

PLoS One. 2015 Jun 17;10(6):e0129383. doi: 10.1371/journal.pone.0129383. eCollection 2015.

Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.高氧可通过下调 VEGF/VEGFR2 通路使玻璃体积血新生血管消退。

Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):918-31. doi: 10.1167/iovs.12-11291.

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability.用于眼部血管生成和血管通透性的抗血管内皮生长因子药物

J Ophthalmol. 2012;2012:852183. doi: 10.1155/2012/852183. Epub 2011 Nov 3.

[Pharmacological treatment for retinopathy of prematurity].[早产儿视网膜病变的药物治疗]

Ophthalmologe. 2011 Aug;108(8):777-85; quiz 786-7. doi: 10.1007/s00347-011-2371-4.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验